Fentanyl
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-26-R-0019
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support has announced its intent to issue a forthcoming solicitation for a national requirements contract for Fentanyl Citrate Injection Solution. This presolicitation notice, identified under procurement number SPE2D2-26-R-0019, outlines the agency’s plan to secure a reliable, long-term supply of this critical pharmaceutical product for federal healthcare customers.
The scope of the anticipated contract encompasses the supply of Fentanyl (preservative-free) 50 micrograms per milliliter (MCG/ML) injection solution, available in a range of vial or ampule sizes: 1 ML, 2 ML, 5 ML, 10 ML, 20 ML, and 50 ML. Each size may be packaged in quantities of 1, 2, 5, 10, 20, or 50 units per pack. The contract is designed to meet the national requirements of multiple federal agencies, including the Department of War (DoW), Department of Veterans Affairs, Indian Health Service, and the Bureau of Prisons. These agencies will access the contracted products through the DLA and VA prime vendor programs, ensuring broad and consistent availability across the federal healthcare system.
A key requirement of this procurement is that competition will be limited to domestic sources. Only vendors whose Active Pharmaceutical Ingredients (API) and Final Dosage Forms (FDF) are manufactured within the United States will be eligible to compete. This restriction is intended to support domestic manufacturing capabilities and ensure supply chain security for this essential medication.
The contract will be structured as a firm-fixed price, requirements-type agreement, featuring a one-year base period with four additional one-year option periods. This arrangement is intended to provide both stability and flexibility in meeting evolving federal demand. The solicitation will be issued as a commercial item acquisition under FAR Part 12, and all qualified domestic sources are encouraged to submit proposals, which will be duly considered by the agency. Annual usage estimates and detailed product specifications will be provided in the Schedule of Supplies section of the solicitation.
The DLA Troop Support, operating under the Department of Defense, is the contracting entity for this procurement. The relevant classification codes for this opportunity are NAICS 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505 (Drugs and Biologicals). The solicitation will be posted on the DLA Bid Board System (DIBBS) and on SAM.gov, with the current projected release date set for November or December 2026. However, DLA reserves the right to adjust this timeline as necessary.
Interested parties are encouraged to monitor the DIBBS and SAM.gov websites for updates and to set up automated notifications for any changes to the presolicitation or solicitation. For further information or to address specific questions, contractors may contact Nancy Fernandez at (445) 737-0731 or [email protected], or Jason Wray at (445) 737-6304 or [email protected].
This opportunity represents a significant, multi-year contract for domestic pharmaceutical manufacturers capable of supplying Fentanyl Citrate Injection Solution in compliance with federal requirements. Contractors with the requisite manufacturing capabilities and a commitment to supporting the federal healthcare system are encouraged to review the forthcoming solicitation in detail upon its release.